CS
ELV icon

Comerica Securities’s Elevance Health ELV Stock Holding History

Comerica Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.56M Sell
3,587
-506
-12% -$230K 0.13% 155
2023
Q2 		$1.82M Sell
4,093
-15
-0.4% -$6.92K 0.13% 161
2023
Q1 		$1.89M Buy
4,108
+90
+2% +$42.8K 0.14% 151
2022
Q4 		$2.06M Buy
4,018
+560
+16% +$284K 0.15% 148
2022
Q3 		$1.57M Buy
3,458
+38
+1% +$18.2K 0.13% 158
2022
Q2 		$1.65M Buy
3,420
+5
+0.1% +$2.47K 0.12% 161
2022
Q1 		$1.68M Sell
3,415
-525
-13% -$240K 0.11% 168
2021
Q4 		$1.83M Sell
3,940
-84
-2% -$35.3K 0.12% 160
2021
Q3 		$1.5M Sell
4,024
-196
-5% -$74.5K 0.11% 177
2021
Q2 		$1.61M Buy
4,220
+87
+2% +$33.2K 0.12% 153
2021
Q1 		$1.48M Buy
4,133
+1,167
+39% +$375K 0.11% 164
2020
Q4 		$952K Buy
2,966
+2
+0.1% +$614 0.08% 211
2020
Q3 		$796K Sell
2,964
-244
-8% -$65.7K 0.07% 212
2020
Q2 		$844K Sell
3,208
-17
-0.5% -$4.54K 0.08% 202
2020
Q1 		$732K Sell
3,225
-153
-5% -$41.7K 0.08% 197
2019
Q4 		$1.02M Sell
3,378
-142
-4% -$39.1K 0.1% 197
2019
Q3 		$845K Sell
3,520
-8
-0.2% -$2.19K 0.09% 216
2019
Q2 		$996K Buy
3,528
+436
+14% +$119K 0.11% 188
2019
Q1 		$887K Sell
3,092
-217
-7% -$62.8K 0.1% 202
2018
Q4 		$869K Buy
3,309
+4
+0.1% +$1.1K 0.12% 182
2018
Q3 		$906K Buy
3,305
+17
+0.5% +$4.41K 0.11% 206
2018
Q2 		$783K Buy
3,288
+127
+4% +$29.4K 0.09% 224
2018
Q1 		$695K Sell
3,161
-7
-0.2% -$1.64K 0.09% 230
2017
Q4 		$713K Buy
3,168
+31
+1% +$6.6K 0.09% 231
2017
Q3 		$596K Buy
3,137
+101
+3% +$19.2K 0.08% 231
2017
Q2 		$571K Sell
3,036
-378
-11% -$67.9K 0.08% 237
2017
Q1 		$565K Buy
3,414
+3
+0.1% +$477 0.09% 236
2016
Q4 		$490K Buy
+3,411
New +$457K 0.2% 122
2015
Q3 		– Sell
-1,270
Closed -$208K – 220
2015
Q2 		$208K Buy
+1,270
New +$203K 0.05% 315

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Comerica Securities's ELV Position: Q3 2023 in Review

Comerica Securities reduced its Elevance Health (ELV) stake by 12% in Q3 2023, selling an estimated $230K and leaving 3,587 shares worth $1.56M. The position accounts for 0.13% of the portfolio, ranked #155.

Comerica Securities first reported a position in ELV in Q2 2015 and has held it in 29 quarters since. The position peaked at $2.06M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Comerica Securities held 3,587 shares of Elevance Health worth $1.56M as of Q3 2023.
  • Comerica Securities sold 506 Elevance Health shares in Q3 2023, an estimated $230K.
  • Elevance Health made up 0.13% of Comerica Securities's portfolio in Q3 2023, its #155 holding.
  • Comerica Securities first reported a position in Elevance Health in Q2 2015 and has held it in 29 quarters since.
  • Comerica Securities's Elevance Health position peaked at $2.06M in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.